The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Alexion Pharmaceuticals Inc

Nasdaq: ALXN
Last

(U.S.) $114.64

Today's change+2.75 +2.46%
Updated June 28 10:13 AM EDT. Delayed by at least 15 minutes.
 

Alexion Pharmaceuticals Inc

Nasdaq: ALXN
Last

(U.S.) $114.64

Today's change+2.75 +2.46%
Updated June 28 10:13 AM EDT. Delayed by at least 15 minutes.

Alexion Pharmaceuticals Inc up sharply

Alexion Pharmaceuticals Inc is up sharply today, rallying (U.S.)$2.75 or 2.46% to (U.S.)$114.64. Over the last five days, shares have lost 7.65% and sit 3.69% above their 52-week low. This security has underperformed the S&P 500 by 34.12% during the last year.

Key company metrics

  • Open(U.S.) $113.00
  • Previous close(U.S.) $111.89
  • High(U.S.) $115.69
  • Low(U.S.) $113.00
  • Bid / Ask(U.S.) $114.62 / (U.S.) $114.69
  • YTD % change-39.90%
  • Volume609,857
  • Average volume (10-day)3,186,688
  • Average volume (1-month)2,165,576
  • Average volume (3-month)1,765,534
  • 52-week range(U.S.) $110.56 to (U.S.) $208.88
  • Beta1.04
  • Trailing P/E159.69×
  • P/E 1 year forward22.13×
  • Forward PEG1.08×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.72
Updated June 28 10:13 AM EDT. Delayed by at least 15 minutes.
S&P TSX1.12%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue701701667636
Total other revenue--------
Total revenue701701667636
Gross profit642643613584
Total cost of revenue59585452
Total operating expense535604512455
Selling / general / administrative233242213221
Research & development167191161126
Depreciation / amortization8980416
Interest expense (income), net operating--------
Unusual expense (income)-13334350
Other operating expenses, total--------
Operating income16697155181
Interest income (expense), net non-operating-24-23----
Gain (loss) on sale of assets--------
Other--------
Income before tax14475139177
Income after tax9267-184170
Income tax, total5183237
Net income9267-184170
Total adjustments to net income--------
Net income before extra. items9267-184170
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9267-184170
Inc. avail. to common incl. extra. items9267-184170
Diluted net income9267-184170
Dilution adjustment--------
Diluted weighted average shares227228226205
Diluted EPS excluding extraordinary itemsvalue per share0.410.29-0.810.83
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.370.42-0.691.07